Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 27, 2026 08:45 ET | Source: 24/7 Market News

Breakthrough Pipelines Ignite Investor Excitement: Retatrutide, VERVE-102, NEO100, and More Set to Transform Medicine

Phase 2 and Phase 3 trials are reshaping expectations across obesity, oncology, gene editing, autoimmune disease, and neurological disorders.
April 14, 2021 08:00 ET | Source: Portnoy Law

Immunovant, Inc. Technology Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm

Investors with losses are encouraged to contact the firm before April 20, 2021; click here to submit trade information LOS ANGELES, April 14, 2021 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises...
February 10, 2021 08:00 ET | Source: Portnoy Law

Immunovant, Inc. Investors: Company Investigated by the Portnoy Law Firm

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Feb. 10, 2021 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Immunovant, Inc. ("Immunovant"...